Genetic variations at urotensin II and urotensin II receptor genes and risk of type 2 diabetes mellitus in Japanese

Peptides

Volumn 25, Issue 10 SPEC. ISS., 2004, Pages 1803-1808

  Suzuki, Susumu ^a   Wenyi, Zong ^a   Hirai, Masashi ^a   Hinokio, Yoshinori ^a   Suzuki, Chitose ^a   Yamada, Takahiro ^a   Yoshizumi, Shinsuke ^a   Suzuki, Michiko ^b   Tanizawa, Yukio ^c   Matsutani, Akira ^c   Oka, Yoshitomo ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHOKEI GAKUIN UNIVERSITY   (Japan)

^c YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Insulin resistance; Normal glucose tolerance; Single nucleotide polymorphism; Type 2 diabetes; Urotensin II; Urotensin II receptor (GPR14)

Indexed keywords

INSULIN; NEUROPEPTIDE RECEPTOR; UNCLASSIFIED DRUG; UROTENSIN II; UROTENSIN II RECEPTOR;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; GENE FREQUENCY; GENETIC VARIABILITY; GLUCOSE TOLERANCE; HUMAN; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

EID: 5144234639     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2004.03.030     Document Type: Article

References (21)

1. R.S. Ames, H.M. Sarau, J.K. Chambers, R.N. Willette, N.V. Aiyar, and A.M. Romanic Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 Nature 401 1999 282 286
2. A.D. Baron Insulin resistance and vascular function J Diabetes Complications 16 2002 92 102
3. D.J. Behm, S.M. Harrison, Z. Ao, K. Maniscalco, S.J. Pickering, and E.V. Grau Deletion of the UT receptor gene results in the selective loss of urotensin-II contractile activity in aortae isolated from UT receptor knockout mice Br J Pharmacol 139 2003 464 472
4. F. Bohm, and J. Pernow Urotensin II evokes potent vasoconstriction in humans in vivo Br J Pharmacol 135 2002 25 27
5. Y. Coulouarn, I. Lihrmann, S. Jegou, Y. Anouar, H. Tostivint, and J.C. Beauvillain Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord Proc Natl Acad Sci USA 95 1998 15803 15808
6. R.A. DeFranzo, R.C. Bonadonna, and E. Ferrannini Pathogenesis of NIDDM: a balanced overview Diabetes Care 15 1992 318 368
7. S.A. Douglas, and E.H. Ohlstein Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease Trends Cardiovasc Med 10 2000 229 237
8. N.A. Elshourbagy, S.A. Douglas, U. Shabon, S. Harrison, G. Duddy, and J.L. Sechler Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey Br J Pharmacol 136 2002 9 22
9. L. Ji, F. Zhu, and B. Luo The role of urotensin II gene in the genetic susceptibility to type 2 diabetes in Chinese population Diabetes 51 Suppl 2 2002 260
10. Q. Liu, S.S. Pong, Z. Zeng, Q. Zhang, A.D. Howard, and D.L. Williams Jr. Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14 Biochem Biophys Res Commun 266 1999 174 178
11. E. Lyon Mutation detection using fluorescent hybridization probes and melting curve analysis Expert Rev Mol Diagn 1 2001 92 101
12. J.J. Maguire, R.E. Kuc, and A.P. Davenport Vasoconstrictor activity of novel endothelin peptide, ET-1(1-31), in human mammary and coronary arteries in vitro Br J Pharmacol 134 2001 1360 1366
13. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
14. M. Matsuda, and R.A. DeFronzo Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp Diabetes Care 22 1999 1462 1470
15. M. Mori, T. Sugo, M. Abe, Y. Shimomura, M. Kurihara, and C. Kitada Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor SENR (GPR14) Biochem Biophys Res Commun 265 1999 123 129
16. Y. Mori, S. Otabe, C. Dina, K. Yasuda, C. Populaire, and C. Lecoeur Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate loci on 7p and 11p Diabetes 51 2002 1247 1255
17. H.P. Nothacker, Z. Wang, A.M. McNeill, Y. Saito, S. Merten, and B. O'Dowd Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction Nat Cell Biol 1 1999 383 385
18. M.A. Sheridan, E.M. Plisetskaya, H.A. Bern, and A. Gorbman Effects of somatostatin-25 and urotensin II on lipid and carbohydrate metabolism of coho salmon Oncorhynchus kisutch Gen Comp Endocrinol 66 1987 405 414
19. R.A. Silvestre, J. Rodriguez-Gallardo, E.M. Egido, and J. Marco Inhibition of insulin release by urotensin II - a study on the perfused rat pancreas Horm Metab Res 33 2001 379 381
20. K. Totsune, K. Takahashi, Z. Arihara, M. Sone, S. Ito, and O. Murakami Increased plasma urotensin II levels in patients with diabetes mellitus Clin Sci (London) 104 2003 1 5
21. Z. Wenyi, S. Suzuki, M. Hirai, Y. Hinokio, Y. Tanizawa, and A. Matsutani Role of urotensin II gene in genetic susceptibility to type 2 diabetes mellitus in Japanese subjects Diabetologia 46 2003 972 976